Sunday, January 26, 2025
HomeIndustriesBiotechnology

Biotechnology

Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program

Eli Lilly and Company and Scorpion Therapeutics, Inc., a private biotechnology company developing small molecule precision oncology therapies, announced a definitive agreement for Lilly...

Read Magazine’s Weekly News Roundup With Rocket Lab, Hiphen , Schneider Electric, Chemify, And More!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Charles River and Akron Bio Partner to Integrate CGMP Materials into Cell Therapy

Charles River Laboratories International, Inc. and Akron Bio, a leading supplier of critical materials and services for advanced therapies, announced the integration of Akron’s...

Verastem Oncology Appoints Matthew E. Ros as COO

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced the appointment of Matthew E. Ros as...

Be Bio Closes $92M Series C, Transitions to Clinical Stage

Be Biopharma, Inc, a leader in B Cell Medicines (BCMs), announced the closing of its $92M Series C financing. The round includes participation from...
0FansLike
0FollowersFollow
spot_img

Hot Topics